Cara Therapeutics, Inc.

NASDAQ:CARA

0.4226 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 2.5560.9912.1353.0044.8666.9336.1653.26110.81323.0034.790.82120.27201.935112.0899.2665.6348.0934.5115.7855.2084.3825.5335.0622.87400000.911000.0790.00702.440.8740.4890.9141.1250.960.1780.9731.0189.973000.627
Cost of Revenue 000.6620.691.5581.4182.592.133.0550.4142.0810.39915.5140.38419.13132.55419.29926.10833.53629.86435.99224.35623.60822.79922.30317.00213.42711.5769.1516.96120.83620.2779.67110.768.5467.5685.5844.6843.3853.4596.2083.22.2011.2752.9340.690.9220.4331.246
Gross Profit 2.5560.9911.4732.3143.3085.5153.5751.1317.75822.5892.7090.4224.758-0.384-17.19679.535-10.033-20.474-25.443-25.353-30.207-19.148-19.226-17.266-17.241-14.128-13.427-11.576-9.151-6.961-19.925-20.277-9.671-10.681-8.539-7.568-3.144-3.81-2.896-2.545-5.083-2.24-2.023-0.302-1.9169.283-0.922-0.433-0.619
Gross Profit Ratio 110.690.770.680.7950.580.3470.7170.9820.5660.5140.2350-8.8870.71-1.083-3.634-3.144-5.62-5.222-3.677-4.387-3.121-3.406-4.9160000-21.87200-135.203-1,219.8570-1.289-4.359-5.922-2.784-4.518-2.333-11.365-0.31-1.8820.93100-0.987
Reseach & Development Expenses 1.3629.30821.95228.37225.45130.3124.33426.0124.69119.90521.27322.83115.51425.22519.13127.1421.06726.10833.53629.86435.99224.35623.60822.79922.30317.00213.42711.5769.1516.96120.83620.2779.67110.768.5467.5685.5844.6843.3853.4596.2083.22.2011.9783.7642.0210.9221.0230.84
General & Administrative Expenses 6.4756.4086.7866.5496.7557.5146.8626.4286.9127.5389.31511.5125.8515.626.3346.6285.1955.3894.5374.6174.2044.9723.8864.7113.2063.6653.6772.9953.7852.6532.3812.0382.0812.4052.12.1611.7761.8331.7331.7911.521.4721.3981.10.7951.0330.5880.7460.952
Selling & Marketing Expenses 0-0.039-0.030000000000000000000000000000000000000000000000
SG&A 6.4756.3696.7866.5496.7557.5146.8626.4286.9127.5389.31511.5125.8515.626.3346.6285.1955.3894.5374.6174.2044.9723.8864.7113.2063.6653.6772.9953.7852.6532.3812.0382.0812.4052.12.1611.7761.8331.7331.7911.521.4721.3981.10.7951.0330.5880.7460.952
Other Expenses 0.7072.620.9520.8741.5580.8610.0290.9680.6650.0320.0320.140.1110.1310.260.3640.3790.6340.9571.1931.2610.9471.0891.21.0020.4670.3110.3680.3670.3310.090.1550.1760.1720.1490.0520000000000000
Operating Expenses 8.54418.29728.73834.92133.76437.85531.22532.43831.60327.47530.6234.34321.39630.87625.49633.79926.28631.51838.09434.48140.21829.3527.51627.5125.5320.68717.12414.57112.9569.63323.23622.31511.77313.40510.9939.7297.4496.6065.2075.257.7284.6723.5993.0784.5593.0541.511.7693.038
Operating Income -5.988-16.214-27.265-32.607-28.032-32.34-27.65-31.307-23.845-4.472-27.911-33.522-1.124-30.876-23.56178.29-17.02-25.884-30.001-29.97-34.433-24.142-23.134-21.977-20.468-17.813-17.124-14.571-12.956-9.633-22.325-22.315-11.773-13.326-10.986-9.729-5.009-5.732-4.718-4.336-6.603-3.712-3.421-2.105-3.5416.919-1.51-1.769-1.165
Operating Income Ratio -2.343-16.361-12.77-10.855-5.761-4.665-4.485-9.6-2.205-0.194-5.827-40.831-0.0550-12.1760.698-1.837-4.594-3.707-6.644-5.952-4.636-5.279-3.972-4.043-6.1980000-24.50600-168.684-1,569.4290-2.053-6.558-9.648-4.744-5.869-3.867-19.219-2.163-3.4780.69400-1.858
Total Other Income Expenses Net -6.488-3.802-3.4310.270.8660.8610.9850.9680.6650.2660.1620.140.1110.1310.260.3640.3790.6340.9571.1931.2610.9471.0891.21.0020.4670.3110.3680.3670.3310.090.1550.1760.1720.1490.0520.0220.0130.0140.0220.0260.0560.0220.009-1.034-1.602-1.129-0.038-0.008
Income Before Tax -12.476-20.016-30.696-32.337-28.032-31.479-26.665-30.339-23.18-4.206-27.749-33.382-1.013-30.745-23.30178.654-16.641-25.25-29.044-28.777-33.172-23.195-22.045-20.777-19.466-17.346-16.813-14.203-12.589-9.302-22.235-22.16-11.597-13.154-10.837-9.677-4.987-5.719-4.704-4.314-6.577-3.656-3.399-2.096-4.5755.317-2.639-1.807-1.173
Income Before Tax Ratio -4.881-20.198-14.378-10.765-5.761-4.54-4.325-9.304-2.144-0.183-5.793-40.66-0.050-12.0420.702-1.796-4.482-3.589-6.379-5.734-4.454-5.031-3.755-3.846-6.0350000-24.40700-166.506-1,548.1430-2.044-6.543-9.62-4.72-5.846-3.808-19.096-2.154-4.4940.53300-1.871
Income Tax Expense 00-0.001-00.807-0.062-0.985-0.968-0.665-0.266-0.162-0.062-0.331-0.323-0.316-0.255-0.132-0.182-0.122-0.166-0.33-0.235-0.085-0.125-0.066-0.152-0.046-0.026-0.145-0.002-0.031-0.189-0.055-0.079-0.145-0.147-0.2-0.035-0.015-0.142-0.032-0.011-0.016-0.0030-0.02-0.007-0.010.005
Net Income -12.476-20.016-30.696-32.337-28.032-31.479-25.68-29.371-22.515-3.94-27.587-33.382-1.013-30.745-23.30178.909-16.509-25.068-28.922-28.611-32.842-22.96-21.96-20.652-19.4-17.194-16.767-14.177-12.444-9.3-22.204-21.971-11.542-13.075-10.692-9.53-4.787-5.684-4.689-4.172-6.545-3.645-3.383-2.093-4.5755.337-2.632-1.797-1.168
Net Income Ratio -4.881-20.198-14.378-10.765-5.761-4.54-4.165-9.007-2.082-0.171-5.759-40.66-0.050-12.0420.704-1.782-4.449-3.574-6.342-5.677-4.409-5.011-3.733-3.832-5.9830000-24.37300-165.506-1,527.4290-1.962-6.503-9.589-4.565-5.818-3.797-19.006-2.151-4.4940.53500-1.863
EPS -0.23-0.37-0.56-0.59-0.52-0.58-0.48-0.55-0.42-0.075-0.52-0.63-0.02-0.61-0.471.68-0.35-0.54-0.62-0.61-0.74-0.58-0.56-0.52-0.51-0.52-0.51-0.43-0.38-0.29-0.81-0.81-0.42-0.48-0.39-0.35-0.19-0.25-0.21-0.18-0.29-0.16-0.22-0.096-0.740.24-0.43-0.29-0.36
EPS Diluted -0.23-0.37-0.56-0.59-0.52-0.58-0.48-0.55-0.42-0.074-0.52-0.63-0.02-0.61-0.471.68-0.35-0.54-0.62-0.61-0.74-0.58-0.56-0.52-0.51-0.52-0.51-0.43-0.38-0.29-0.81-0.81-0.42-0.48-0.39-0.35-0.19-0.25-0.21-0.18-0.29-0.16-0.22-0.096-0.740.24-0.43-0.29-0.35
EBITDA -10.443-18.029-28.672-31.651-28.839-31.035-26.232-31.619-23.784-4.409-27.848-33.46-1.062-30.815-23.49878.352-16.969-25.836-29.953-29.922-34.383-24.092-23.084-21.925-20.389-17.699-16.999-14.446-12.831-9.51-22.203-22.041-11.676-13.167-10.795-9.729-4.815-5.539-4.525-4.143-6.406-3.516-3.224-1.908-3.3447.116-1.312-1.571-0.911
EBITDA Ratio -4.086-18.193-12.751-10.827-5.761-4.656-4.476-9.6-2.205-0.192-5.814-40.831-0.0520-12.1440.699-1.831-4.586-3.701-6.644-5.943-4.626-5.268-3.972-4.028-6.1580000-24.37200-162.114-1,465.1430-1.973-6.338-9.254-4.744-5.694-3.663-18.112-2.163-3.2850.71400-1.453